Cambridge Isotope Laboratories, Inc. Expands 13C Production Capacity With North Star Project
Cambridge Isotope Laboratories, Inc. (CIL), the global leader in 13C and 13C urea production, is excited to announce the startup of its North Star project, significantly...
Vibrant Wellness Advances Food Sensitivity Research With New Clinical Trial
Vibrant Wellness, a leader in specialty lab testing, announced the release of new research on food sensitivity, highlighting their ongoing commitment to personalized wellness and...
Data4Cure to Present at the BIO International Convention 2024
Data4Cure, a leading biomedical data-to-knowledge company, today announced its upcoming presentation at the BIO International Convention 2024 taking place June 3-6, 2024, in San Diego,...
Cambridge Isotope Laboratories, Inc. Launches 12C Methane QG Diamond for Quantum Applications
Cambridge Isotope Laboratories, Inc. (CIL) is pleased to announce the release of highly enriched 12C methane with low nitrogen content called 12C Methane QG Diamond™ for...
Revolutionizing Cannabis Extraction: ENTEXS Unveils Groundbreaking Ethanol Extraction Platform With Inline THC Remediation
This represents a monumental advancement for the hemp industry — a comprehensive processing solution from biomass input to T-free crude and/or distillate. This pioneering breakthrough...
Flightpath Biosciences Begins Human Clinical Testing of the World’s First Narrow-Spectrum Antibiotic Targeting Lyme Disease
Flightpath Biosciences Inc., a clinical-stage life sciences company developing therapeutics to treat infectious diseases, announced today that the first healthy volunteer participants have been dosed...
Lithuanian Biotech Pioneer ‘Nando’ Embarks on Global Expansion With New Management Team and Innovative Production Line
"Nando", a leading Lithuanian-owned biotechnology company known for its groundbreaking work in developing microbiological products for agriculture, that helped to save up to 50M on...
CARDIO inCode-Score (CIC-Score) Presentation at the European Society of Cardiology
GENinCode Plc, the polygenics company focused on the prevention of cardiovascular disease and ovarian cancer, gave details of a presentation by Kaiser Permanente at the...
Cambridge Isotope Laboratories (CIL) Shows Long-Term Commitment to Xenia, Ohio, Facility With New Land Purchase
Cambridge Isotope Laboratories, Inc. (CIL) has acquired an additional 14.8 acres of land at its Cambridge Isotope Separations (CIS) Xenia, Ohio location. Mike Steiger, Vice...
CARDIO inCode-Score Clinical Publication on Polygenic Risk of Coronary Heart Disease
US Study Publication in the American Journal of Preventive Cardiology GENinCode Plc (www.genincode.com) the polygenics company focused on the prevention of cardiovascular disease and ovarian...